In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

被引:2001
作者
Fischer, D
Li, YX
Ahlemeyer, B
Krieglstein, J
Kissel, T
机构
[1] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
[2] Schwarz Pharma AG, D-40789 Monheim, Germany
[3] Univ Marburg, Dept Pharmacol & Toxicol, D-35032 Marburg, Germany
关键词
in vitro cytotoxicity testing; L929; fibroblasts; polycation; hemolysis; apoptosis;
D O I
10.1016/S0142-9612(02)00445-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
A comparative in vitro cytotoxicity study with different water-soluble, cationic macromolecules which have been described as gene delivery systems was performed. Cytotoxicity in L929 mouse fibroblasts was monitored using the MTT assay and the release of the cytosolic enzyme lactate dehydrogenase (LDH). Microscopic observations were carried out as indicators for cell viability. Furthermore, hemolysis of erythrocytes was quantified spectrophotometrically. To determine the nature of cell death induced by the polycations, the nuclear morphology after DAPI staining and the inhibition of the toxic effects by the caspase inhibitor zVAD.fmk were investigated. All assays yielded comparable results and allowed the following ranking of the polymers with regard to cytotoxicity: Poly(ethylenimine) = poly(L-lysine) > poly(diallyl-dimethyl-ammonium chloride) > diethylaminoethyl-dextran > poly (vinyl pyridinium bromide) > Starburst dendrimer > cationized albumin > native albumin. The magnitude of the cytotoxic effects of all polymers were found to be time- and concentration dependent. The molecular weight as well as the cationic charge density of the polycations were confirmed as key parameters for the interaction with the cell membranes and consequently, the cell damage. Evaluating the nature of cell death induced by poly(ethylenimine), we did not detect any indication for apoptosis suggesting that the polymer induced a necrotic cell reaction. Cell nuclei retained their size, chromatin was homogenously distributed and cell membranes lost their integrity very rapidly at an early stage. Furthermore, the broad spectrum caspase inhibitor zVAD.fmk did not inhibit poly(ethylenimine)-induced cell damage. Insights into the structure-toxicity relationship are necessary to optimize the cytotoxicity and biocompatibility of non-viral gene delivery systems. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1121 / 1131
页数:11
相关论文
共 30 条
[1]   ANTI-NEOPLASTIC ACTIVITY OF POLY(L-LYSINE) WITH SOME ASCITES TUMOR-CELLS [J].
ARNOLD, LJ ;
DAGAN, A ;
GUTHEIL, J ;
KAPLAN, NO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (07) :3246-3250
[2]  
Behr JP, 1997, CHIMIA, V51, P34
[3]   Effect of size and serum proteins on transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles [J].
Cherng, JY ;
vandeWetering, P ;
Talsma, H ;
Crommelin, DJA ;
Hennink, WE .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :1038-1042
[4]   IN-VITRO CYTOTOXICITY OF MACROMOLECULES IN DIFFERENT CELL-CULTURE SYSTEMS [J].
CHOKSAKULNIMITR, S ;
MASUDA, S ;
TOKUDA, H ;
TAKAKURA, Y ;
HASHIDA, M .
JOURNAL OF CONTROLLED RELEASE, 1995, 34 (03) :233-241
[5]  
DAUTZENBERG H, 1994, POLYELECTROLYTES
[6]   Poly-L-glutamic acid derivatives as vectors for gene therapy [J].
Dekie, L ;
Toncheva, V ;
Dubruel, P ;
Schacht, EH ;
Barrett, L ;
Seymour, LW .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :187-202
[7]  
Ferruti P, 1997, P INT S CONTROL REL, V24, P45
[8]   Cationized human serum albumin as a non-viral vector system for gene delivery?: Characterization of complex formation with plasmid DNA and transfection efficiency [J].
Fischer, D ;
Bieber, T ;
Brüsselbach, S ;
Elsässer, HP ;
Kissel, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 225 (1-2) :97-111
[9]   A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine:: Effect of molecular weight on transfection efficiency and cytotoxicity [J].
Fischer, D ;
Bieber, T ;
Li, YX ;
Elsässer, HP ;
Kissel, T .
PHARMACEUTICAL RESEARCH, 1999, 16 (08) :1273-1279
[10]  
FISCHER D, 2000, BIOMATERIALS DRUG DE, P195